Connect with us


EU Clears EssilorLuxottica’s $8.5B Acquisition of GrandVision

EssilorLuxottica agreed to sell 351 stores.




The European Commission has approved EssilorLuxottica’s plan to acquire GrandVision, a Netherlands-based optical retailer, in a deal worth up to $8.5 billion.

In order to secure the anti-trust approval, EssilorLuxottica agreed to sell 351 stores in three countries.

“EssilorLuxottica offers leading brands of eyewear products, such as Ray-Ban, whilst GrandVision is a major optical retailer in Europe,” said EU Executive Vice-President Margrethe Vestager, in charge of competition policy. “Our in-depth investigation showed that, by acquiring a greater retail footprint, EssilorLuxottica could have degraded the access of rival opticians to EssilorLuxottica’s branded eyewear products in Belgium, Italy and the Netherlands. This would mean less choice and higher-priced eyewear for consumers in those countries. The remedies proposed by EssilorLuxottica will address this risk by ensuring that competition at the optical retail level remains vibrant at national level and to the benefit of customers in these countries.”


Reuters notes that EssilorLuxottica “is at loggerheads with Dutch retail chain GrandVision over the latter’s management of the coronavirus crisis, with litigation currently before a Dutch court.”

More from the EU:

Today’s decision follows an in-depth investigation of the proposed acquisition of GrandVision by EssilorLuxottica. EssilorLuxottica is the largest supplier of ophthalmic lenses and eyewear, both worldwide and in Europe, and has a very large portfolio of well-known brands such as Ray-Ban and Oakley. Additionally, EssilorLuxottica is active in the retail sale of optical products, notably in Italy and the UK. GrandVision is a globally active eyewear retailer, which operates some of the largest optical chains throughout Europe, such as GrandOptical and Pearle. EssilorLuxottica sells its products to optical retailers, including GrandVision, which resell them to final consumers.

The Commission’s investigation

The Commission’s in-depth investigation focused in particular on competition concerns that could arise from the combination of EssilorLuxottica’s strong market position in the wholesale supply of optical products (i.e., lenses and eyewear) and GrandVision’s leading presence in the retail distribution of these products.

During its investigation, the Commission received feedback from over 4,300 opticians throughout Europe.

In its assessment the Commission took into account the extent to which the companies are present at each level of the supply chain, the extent to which retailers have alternative, credible suppliers to turn to in those countries, the proportion of stores that sell the most important EssilorLuxottica brands in those countries and the expected reaction of consumers. The Commission also conducted economic modelling to assess the merged entity’s incentive to raise the wholesale prices it charges to retail competitors, as well as its incentive to raise the retail prices that it charges to consumers in its own stores.

Following its in-depth market investigation, the Commission had concerns that the transaction, as initially notified, could worsen rival opticians’ access to EssilorLuxottica’s products in Belgium, Italy and the Netherlands. In particular, the Commission found that:

-In all those countries the merged entity would have the ability and incentive to leverage its important position in the wholesale supply of frames to make it more difficult for competing retailers to access eyewear manufactured and distributed by the merged entity, for example by reducing choice or raising prices charged to retailers for frames. This would weaken the competition in these markets, and ultimately leading to higher prices or less choice for consumers.

-For Italy, the transaction would in addition bring together the two largest retailers operating in the market through chains, thus creating the largest player on the optical retail market, almost three times as large as the second player. This would considerably weaken competition in the Italian market, ultimately harming consumers.

The proposed remedies

To address the competition concerns identified by the Commission, EssilorLuxottica offered to divest part of its retail operations in each of the countries in which the Commission had concerns. In particular:

-In Belgium, the GrandOptical chain and its 35 stores will be sold but without the brand name. The purchaser will have a license while rebranding these stores to its own choice of name.

-In Italy, the merged entity will divest a total of 174 stores, which includes the whole of EssilorLuxottica’s VistaSi chain together with 72 stores from the “GrandVision by” chain. The VistaSi brand will be transferred and the “GrandVision by” stores will either be rebranded to VistaSi or to the purchaser’s own brand.

-In the Netherlands, 142 stores from the EyeWish chain will be sold, together with the brand name. The merged entity will keep some stores from this chain and will have to rebrand them under a new name.

-The remedy package also contains additional safeguards to ensure the smooth transfer of the divestment business to the purchaser, including transitional supply and support arrangements.

The Commission concluded that the proposed transaction, as modified by the commitments, would no longer raise competition concerns. In particular, the remedies limit the retail footprint of the merged entity and reduce its incentive to restrict competitors’ access to optical frames in Belgium, Italy, and the Netherlands, while creating or strengthening a credible optical retail competitor at national level in these countries. The Commission’s decision is conditional upon full compliance with the commitments.

Companies and products

EssilorLuxottica is a French-Italian vertically integrated multinational corporation based in Paris. It was founded on 1 October 2018 after the combination of the Italian Luxottica Group with the French Essilor International. EssilorLuxottica is active in (i) every phase of the ophthalmic (corrective) lens development, from design to manufacture to wholesale, (ii) the design, manufacture and distribution of eyewear, namely optical frames and sunglasses, and (iii) the retail sales of optical products which counts over 9,100 retail stores globally. The transaction that led to the creation of EssilorLuxottica was cleared without conditions by the Commission on 1 March 2018.

GrandVision is a Dutch-based global player active in optical retail with a focus on delivering eye care to customers globally. GrandVision provides eye care services such as eye tests and sells a range of products including prescription glasses including frames and lenses, contact lenses and contact lens care products, as well as sunglasses both plain and with prescription lenses. GrandVision operates over 7,000 stores in more than 40 different countries across Europe, North and Latin America and Asia.

Merger control rules and procedures

The transaction was notified to the Commission on 23 December 2019 and the Commission opened an in-depth investigation on 6 February 2020.

The Commission has the duty to assess mergers and acquisitions involving companies with a turnover above certain thresholds (see Article 1 of the Merger Regulation) and to prevent concentrations that would significantly impede effective competition in the EEA or any substantial part of it.

The vast majority of notified mergers do not pose competition problems and are cleared after a routine review. From the moment a transaction is notified, the Commission generally has 25 working days to decide whether to grant approval (Phase I) or to start an in-depth investigation (Phase II).

There are currently three on-going Phase II merger investigations: the proposed acquisition of DSME by HHiH, the proposed acquisition of Transat by Air Canada, and the proposed acquisition of Willis Towers Watson by Aon.

More information will be available on the competition website, in the Commission’s public case register under the case number M.9569.




The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular